The Leader in Quality Life Science Training

Healthy and Infected: What We Know About the Asymptomatic Spread of COVID-19

August 25, 2020

One of the mysteries of the COVID-19 pandemic has been that seemingly healthy individuals can spread the virus to others. This method of transmission, known as asymptomatic spread, has made it difficult to isolate infected individuals and prevent outbreaks. 


But how does asymptomatic spread work exactly? And what consequences will it have if we reopen schools and businesses without a vaccine? 



The Difference Between Asymptomatic and Presymptomatic 

By the time an individual infected with COVID-19 starts showing the telltale symptoms of dry cough, fever, and fatigue, they may have already spread the virus to dozens of people. Such a patient is known as a presymptomatic transmitter. 


An asymptomatic transmitter, on the other hand, never feels sick. Asymptomatic spread becomes particularly challenging for public health officials when the virus in question is as highly infectious as SARS-CoV-2. Moreover, this mode of transmission is not as uncommon as we once thought. 



According to estimates from the CDC, up to 40% of infections in the U.S. are asymptomatic. This type of transmission isn’t exclusive to COVID-19, either—we see the same behavior in other, less lethal viruses, such as influenza and common colds. 


What Do We Know About Asymptomatic COVID-19 Spread?

A study from South Korea published in early August showed that people without symptoms carry just as much virus in their nose, throat, and lungs as their symptomatic counterparts—and for nearly the same amount of time. 


The study analyzed 193 symptomatic and 110 asymptomatic patients isolated at a community treatment center in Cheonan. Of patients who were initially asymptomatic, around 30% were truly asymptomatic, while the rest turned out to be presymptomatic. 


Back in June, the WHO was criticized for, and promptly withdrew, a comment claiming that asymptomatic transmission of COVID-19 was “rare.” The 30% figure from South Korea aligns with what other scientists have modeled as a 40% asymptomatic transmission rate. In a television interview, Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases, referred to the same 40% figure. 


The results from South Korea confirm what we’ve long suspected—that seemingly healthy individuals can indeed spread the virus to others. 



The likelihood of asymptomatic transmission, however, is still poorly understood. While a lack of symptoms may mean less coughing and sneezing, asymptomatic people may carry on with their business, infecting others in the process. 


Who Is More Likely to Be Asymptomatic? 

When it comes to the virus’s general prognosis, it appears that younger people are spared the worst outcomes. According to an analysis of more than 17 million British health records, risk of dying from a COVID-19 infection is linked to old age. But why is that the case? 


One of the theories currently gaining traction in the scientific community is that younger people have increased exposure to more than one coronavirus, lending some protection or immunity against COVID-19. 


Historically, asymptomatic spread has been overlooked by researchers. We tend to focus on patients who require immediate care. 



Few studies have documented the silent spread of viruses. One study conducted in New York City in 2019 reported that 55% of people who tested positive with a respiratory virus were symptom-free. Moreover, asymptomatic infection rates trended upwards of 70%. Despite these findings, asymptomatic spread of viruses remains controversial among researchers


Taking a Step Forward Against COVID-19

More information about SARS-CoV-2 is coming to light every day. Understanding the nature of the virus will have an enormous impact on our projections and reopening policies. 


What are you doing to keep your organization at the forefront of response efforts? Sharpen your organization’s skill set with hands-on training and certification courses from The Center for Professional Innovation and Education (CfPIE).


Get in touch with a member of the CfPIE team by calling 1-610-648-7550 or emailing [email protected]


Call Us
paper_plane

Need more information on our life-science training course?

Get In Touch With Us Today!

Contact Us

Blog Categories

By The Center for Professional Innovation and Education November 4, 2024
Discover the meaning of cGMP (current Good Manufacturing Practices) and why compliance is crucial for quality, safety, and regulatory success in pharmaceutical and biotech industries.
A scientist is looking through a microscope in a laboratory.
By The Center for Professional Innovation and Education October 8, 2024
Specialized life science courses provide the skills to meet FDA and EMA regulations, leverage advanced research methods, and understand industry best practices while fostering innovation.
Share by: